ChristophPohlMD

PubMed

• 20 citations
  MRI-based prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis using SVM and lesion geometry.
  Kerstin Bendfeldt, Bernd Taschler, Laura Gaetano, Philip Madoerin, Pascal Kuster, Nicole Mueller-Lenke, Michael Amann, Hugo Vrenken, Viktor Wottschel, Frederik Barkhof...> ;Brain Imaging and Behavior. 2019 Oct 1
• 21 citations
  New insights into the prevalence of depressive symptoms and depression in rheumatoid arthritis - Implications from the prospective multicenter VADERA II study.
  Matthias Englbrecht, Rieke Alten, Martin Aringer, Christoph Baerwald, Harald Burkhardt, Nancy Eby, J.-P. Flacke, G. Fliedner, U. Henkemeier, Michael Hofmann, Stefan Kl...> ;Plos One. 2019 May 28
• 22 citations
  Predictive validity of NEDA in the 16- and 21-year follow-up from the pivotal trial of interferon beta-1b:
  Douglas S. Goodin, Anthony T. Reder, Anthony Traboulsee, David Kb Li, Dawn Langdon, Gary Cutter, Stuart D. Cook, Timothy O'Donnell, Marcelo Kremenchutzky, Joel Oger, R...> ;Multiple Sclerosis. 2019 May 1
• 7 citations
  Effect of HLA-DRB1 alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trials.
  Dorothea Buck, Till M.F. Andlauer, Wilmar Igl, Eva-Maria Wicklein, Mark Mühlau, Frank Weber, Karl Köchert, Christoph Pohl, Barry G. W. Arnason, Giancarlo Comi, Stuart ...> ;Multiple Sclerosis. 2019 Apr 1
• 9 citations
  Health Equity Considerations for Developing and Reporting Patient-reported Outcomes in Clinical Trials: A Report from the OMERACT Equity Special Interest Group.
  Jennifer Petkovic, Jennifer L. Barton, Caroline A Flurey, Niti Goel, Christie M. Bartels, Cheryl Barnabe, Maarten de Wit, Anne Lyddiatt, Diane Lacaille, Vivian Welch, ...> ;The Journal of Rheumatology. 2017 Nov 1
• 9 citations
  An OMERACT Initiative Toward Consensus to Identify and Characterize Candidate Contextual Factors: Report from the Contextual Factors Working Group.
  Monika E. Finger, Annelies Boonen, Thasia G. Woodworth, Reuben Escorpizo, Robin Christensen, Sabrina Mai Nielsen, Amye L. Leong, Marieke Voshaar, Caroline A Flurey, Na...> ;The Journal of Rheumatology. 2017 Nov 1
• 22 citations
  Content and Construct Validity, Reliability, and Responsiveness of the Rheumatoid Arthritis Flare Questionnaire: OMERACT 2016 Workshop Report.
  Susan J. Bartlett, Skye Barbic, Vivian P. Bykerk, Ernest Choy, Rieke Alten, Robin Christensen, Alfons den Broeder, Bruno Fautrel, Daniel E. Furst, Francis Guillemin, S...> ;The Journal of Rheumatology. 2017 Oct 1
• 16 citations
  Toward the Development of a Core Set of Outcome Domains to Assess Shared Decision-making Interventions in Rheumatology: Results from an OMERACT Delphi Survey and Conse...
  Karine Toupin-April, Jennifer L. Barton, Liana Fraenkel, Linda C. Li, Peter Brooks, Maarten de Wit, Dawn Stacey, Alexa Meara, Beverley Shea, Anne Lyddiatt, Cathie Hofs...> ;The Journal of Rheumatology. 2017 Oct 1
• 62 citations
  Sodium intake and multiple sclerosis activity and progression in BENEFIT.
  Kathryn C. Fitzgerald, Kassandra L. Munger, Hans-Peter Hartung, Mark S. Freedman, Xavier Montalban, Gilles Edan, Eva-Maria Wicklein, Ernst-Wilhelm Radue, Ludwig Kappos...> ;Annals of Neurology. 2017 Jul 1
• 4 citations
  The OMERACT First-time Participant Program: Fresh Eye from the New Guys
  Victor S. Sloan, Shawna Grosskleg, Christoph Pohl, George A. Wells, Jasvinder A. Singh> ;The Journal of Rheumatology. 2017 May 15
• 26 citations
  Validation of Standardized Questionnaires Evaluating Symptoms of Depression in Rheumatoid Arthritis Patients: Approaches to Screening for a Frequent Yet Underrated Cha...
  Matthias Englbrecht, Rieke Alten, Martin Aringer, Christoph Baerwald, Harald Burkhardt, Nancy Eby, G. Fliedner, Bettina Gauger, U. Henkemeier, M. W. Hofmann, Stefan Kl...> ;Arthritis Care & Research. 2017 Jan 1
• 89 citations
  The 11-year long-term follow-up study from the randomized BENEFIT CIS trial
  Ludwig Kappos, Gilles Edan, Mark S. Freedman, Xavier Montalban, Hans-Peter Hartung, Bernhard Hemmer, Edward Fox, Frederik Barkhof, Sven Schippling, Andrea Schulze, Dir...> ;Neurology. 2016 Sep 6
• 31 citations
  Incidence and course of depression in multiple sclerosis in the multinational BEYOND trial.
  Sven Schippling, Paul O'Connor, Volker Knappertz, Christoph Pohl, Timon Bogumil, Gustavo Suarez, Stuart D. Cook, Massimo Filippi, Hans-Peter Hartung, Giancarlo Comi, D...> ;Journal of Neurology. 2016 May 13
• 20 citations
  Development of a draft core set of domains for measuring shared decision making in osteoarthritis: An OMERACT working group on shared decision making
  Karine Toupin-April, Jennifer L. Barton, Liana Fraenkel, Linda C. Li, Viviane Grandpierre, Francis Guillemin, Tamara Rader, Dawn Stacey, Janet Jull, Jennifer Petkovic,...> ;The Journal of Rheumatology. 2015 Dec 1
• 16 citations
  Toward Ensuring Health Equity: Readability and Cultural Equivalence of OMERACT Patient-Reported Outcome Measures
  Jennifer Petkovic, Jonathan A. Epstein, R Buchbinder, Vivian Welch, Tamara Rader, Anne Lyddiatt, Rosemary Anne Clerehan, Robin Christensen, Annelies Boonen, Niti Goel,...> ;The Journal of Rheumatology. 2015 Dec 1
• 109 citations
  Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b
  Kathryn C. Fitzgerald, Kassandra L. Munger, Karl Köchert, Giancarlo Comi, Stuart D. Cook, Douglas S. Goodin, Massimo Filippi, Hans-Peter Hartung, Douglas Jeffery, Paul...> ;JAMA Neurology. 2015 Dec 1
• 8 citations
  No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT.
  Kassandra L Munger, Kathryn C Fitzgerald, Mark S Freedman, Hans-Peter Hartung, David H Miller, Xavier Montalbán, Gilles Edan, Frederik Barkhof, Gustavo Suarez, Ernst-W...> ;Neurology. 2015 Nov 10
• 2 citations
  The OMERACT First-time Participant (“Newbie”) Program: Initial Assessment and Lessons Learned
  Victor S. Sloan, Shawna Grosskleg, Christoph Pohl, George A. Wells, Jasvinder A. Singh> ;The Journal of Rheumatology. 2015 Oct 1
• 3 citations
  Predictors of disease activity in 857 patients with MS treated with interferon beta-1b
  Hans-Peter Hartung, Ludwig Kappos, Douglas S. Goodin, Paul O'Connor, Massimo Filippi, Barry G. W. Arnason, Giancarlo Comi, Stuart D. Cook, Douglas Jeffery, John Petkau...> ;Journal of Neurology. 2015 Aug 5
• 38 citations
  Feasibility and Domain Validation of Rheumatoid Arthritis (RA) Flare Core Domain Set: Report of the OMERACT 2014 RA Flare Group Plenary.
  Susan J. Bartlett, Vivian P. Bykerk, Roxanne Cooksey, Ernest Choy, Rieke Alten, Robin Christensen, Daniel E. Furst, Francis Guillemin, Serena Halls, Sarah Hewlett, Amy...> ;The Journal of Rheumatology. 2015 Nov 1
• 39 citations
  Molecular mechanism underlying the impact of vitamin D on disease activity of MS
  Kassandra L. Munger, Karl Köchert, Kelly Claire Simon, Ludwig Kappos, Chris H. Polman, Mark S. Freedman, Hans Hartung, David Miller, Xavier Montalban, Gilles Edan, Fre...> ;Annals of Clinical and Translational Neurology. 2014 Aug 1
• 65 citations
  Establishing a Core Domain Set to Measure Rheumatoid Arthritis Flares: Report of the OMERACT 11 RA Flare Workshop
  Vivian P. Bykerk, Elisabeth Lie, Susan J. Bartlett, Rieke Alten, Annelies Boonen, Robin Christensen, Daniel E. Furst, Sarah Hewlett, Amye L. Leong, Anne Lyddiatt, Lyn ...> ;The Journal of Rheumatology. 2014 Apr 1
• 306 citations
  Vitamin D as an early predictor of multiple sclerosis activity and progression.
  Alberto Ascherio, Kassandra L. Munger, Rick White, Karl Köchert, Kelly Claire Simon, Chris H. Polman, Mark S. Freedman, Hans-Peter Hartung, David Miller, Xavier Montal...> ;JAMA Neurology. 2014 Mar 1
• 18 citations
  Interferon beta-1b reduces black holes in a randomised trial of clinically isolated syndrome.
  G. J. A. Nagtegaal, Christoph Pohl, Mike P. Wattjes, Hanneke E. Hulst, Mark S. Freedman, Hans-Peter Hartung, David Miller, Xavier Montalban, Ludwig Kappos, Gilles Edan...> ;Multiple Sclerosis. 2014 Jan 31
• 68 citations
  Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFIT
  Gilles Edan, Ludwig Kappos, Xavier Montalban, Chris H. Polman, Mark S. Freedman, Hans-Peter Hartung, David Miller, Frederik Barkhof, Julia Herrmann, Vivian Lanius, Bri...> ;Journal of Neurology, Neurosurgery, and Psychiatry. 2014 Nov 1
• Join now to see all